Similar results were obtained by Kominsky et al., who observed that reducing TGFBR2 expression and blocking the TGF-β pathway inhibited ccRCC metastasis to bone [145]. The gene discussed is TGFBR2; the disease is nonpapillary renal cell carcinoma.